XML 46 R39.htm IDEA: XBRL DOCUMENT
v3.24.3

License and collaboration agreement with Acadia Pharmaceuticals Inc - Additional Information (Details) - Acadia Pharmaceuticals Inc. - USD ($) $ in Millions | 1 Months Ended | 9 Months Ended
--- | --- | ---
Jan. 31, 2022 | Sep. 30, 2024
License And Collaboration Agreement [Line Items] |  |
Upfront Payment received | $ 60.0 |
Potential milestone payments receivable | $ 907.5 |
Remaining upfront consideration |  | $ 39.9

X
- Definition License and collaboration agreement. + References No definition available. + Details
Name: | stok_LicenseAndCollaborationAgreementLineItems
Namespace Prefix: | stok_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Milestone payments receivable. + References No definition available. + Details
Name: | stok_MilestonePaymentsReceivable
Namespace Prefix: | stok_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Remaining upfront consideration. + References No definition available. + Details
Name: | stok_RemainingUpfrontConsideration
Namespace Prefix: | stok_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payment received. + References No definition available. + Details
Name: | stok_UpfrontPaymentReceived
Namespace Prefix: | stok_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=stok_AcadiaPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |